Concepedia

Adrian Freeman

AF

Statistics

Publications

4

Citations

81

H-Index

4

Active since

2022

Affiliations

AstraZeneca (United Kingdom)(Current)

Imperial College London

Adrian Freeman is an author at AstraZeneca (United Kingdom) specializing in life sciences, cell signaling, and pulmonary hypertension.

Publications per year

2022–2024

4

Publications

4

An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis

Alexander J. Ainscough, Timothy J. N. Smith, Maike Haensel et al. · Communications Biology · 2022 · 33 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Machine Learning and Artificial Intelligence in Drug Repurposing—Challenges and Perspectives

Ezequiel Anokian, Judith Bernett, Adrian Freeman et al. · Drug repurposing · 2024 · 19 citations · Full text

Medicine, Bioinformatics, Pharmacology +17

StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit

Chiyun Lee, Junxia Lin, Andrzej Prokop et al. · Frontiers in Genetics · 2022 · 16 citations · Full text

Life Sciences, Bioinformatics, Biomedical Informatics +15

Inhibition of the glucocorticoid‐activating enzyme 11β‐hydroxysteroid dehydrogenase type 1 drives concurrent 11‐oxygenated androgen excess

Lina Schiffer, Imken Oestlund, Jacky L. Snoep et al. · The FASEB Journal · 2024 · 13 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

1–4 of 4